Citadel Advisors’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Buy
569,090
+555,549
+4,103% +$2.19M ﹤0.01% 6533
2025
Q4
$55.1K Sell
13,541
-6,538,436
-100% -$29.3M ﹤0.01% 11993
2025
Q3
$23.3M Buy
6,551,977
+3,596,930
+122% +$13M 0.02% 2141
2025
Q2
$8.07M Sell
2,955,047
-447,564
-13% -$923K 0.01% 3343
2025
Q1
$5.72M Buy
3,402,611
+2,197,074
+182% +$6.14M 0.01% 3665
2024
Q4
$1.97M Buy
1,205,537
+1,026,243
+572% +$3.06M ﹤0.01% 5663
2024
Q3
$746K Buy
179,294
+119,919
+202% +$630K ﹤0.01% 7417
2024
Q2
$324K Sell
59,375
-1,827,781
-97% -$14.6M ﹤0.01% 8983
2024
Q1
$18.9M Buy
1,887,156
+1,847,280
+4,633% +$13.8M 0.02% 2129
2023
Q4
$163K Sell
39,876
-245,596
-86% -$905K ﹤0.01% 10262
2023
Q3
$1.1M Buy
285,472
+166,040
+139% +$892K ﹤0.01% 6356
2023
Q2
$712K Sell
119,432
-1,469,949
-92% -$8.47M ﹤0.01% 7160
2023
Q1
$5.2M Buy
1,589,381
+737,578
+87% +$2.95M 0.01% 3741
2022
Q4
$3.36M Sell
851,803
-335,609
-28% -$1.64M ﹤0.01% 4555
2022
Q3
$7.13M Buy
1,187,412
+1,119,195
+1,641% +$8.08M 0.01% 3290
2022
Q2
$439K Buy
68,217
+32,950
+93% +$210K ﹤0.01% 8940
2022
Q1
$291K Sell
35,267
-163,896
-82% -$1.33M ﹤0.01% 10660
2021
Q4
$3.08M Buy
+199,163
New +$3.84M ﹤0.01% 5283
2021
Q3
Sell
-59,693
Closed -$1.25M 14673
2021
Q2
$1.17M Sell
59,693
-51,765
-46% -$1.17M ﹤0.01% 7934
2021
Q1
$3.73M Buy
+111,458
New +$3.63M ﹤0.01% 4930

Other funds holding SANA